Diethylstilbestrol diphosphate

This classification denotes a hormonal antineoplastic agent with the molecular formula C18H22O8P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0E0NMA80F, chemically known as 4,4-stilbenediol, .alpha., .alpha.-diethyl-, diphosphate, disodium salt but more generally known as fosfestrol, which bears US NIH Compound Identifier 3032325. European Medicines Agency schedules Fosfestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07795MIG. World Health Organization schedules fosfestrol in its Anatomical Therapeutic Chemical (ATC) Classification. FOSFESTROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule diethylstilbestrol diphosphate under HS 29072900. SMILES: CC/C(=C(/CC)\C1CCC(CC1)OP(=O)(O)O)/C2CCC(CC2)OP(=O)(O)O.